COURSE TITLE:

 

COURSE NUMBER:

 

SEMESTER HOURS:

 

REQUIRED:

 

PREREQUISITES:

PHARMACOTHERAPEUTICS II

 

PHA 460

 

7 hours

 

YES

 

PHR 241, 242

 



Click “Play” for a welcome message!



Approved:

8/1/08 – Invited Lecturers

8/2/08 – Department Chair

8/5/08 – Curriculum Committee

 pharmacyonline.creighton.edu/pha460/toc.htm

 

 

 

Copyright:

2009 Keith Christensen, Pharm D, BCPS

 

 

 

 

Grading

Technology Readiness Assessment

 

BULLET

DESCRIPTION:

 

PHA460 is the second course in a two-semester sequence which provides in-depth instruction into the pharmacotherapeutic management of the major medical diseases.  Emphasis is placed on the efficacy, safety, and comparative value of drug therapy in over 150 pathological disease states affecting all major human organ systems.  Didactic instruction is combined with a practical case based recitation. The case studies portion of this course allows the student pharmacist to integrate and apply the didactic knowledge into specific cases in preparation for the experiential portion of the curriculum.

 

 

JUSTIFICATION:

Pharmacotherapeutics is one of the foundation courses for the provision of pharmaceutical care.  It is essential that graduates with a Doctor of Pharmacy degree be thoroughly knowledgeable in all areas of pharmacotherapeutics.  Furthermore, the student must be able to integrate and apply this knowledge base to specific patient cases.

 

COURSE
OBJECTIVES:      

 

Objective

 

Educational Outcome

 

Bloom’s Taxonomy Level

1. Describe the pathophysiology and clinical course of the major disease processes.

5

II

2. Design and/or evaluate a specific pharmaceutical care plan for the management of major disease processes and provide alternative treatment measures based upon clinical and demographic characteristics.

4, 5

V, VI

3. Discuss risk to benefit ratios of various therapeutic modalities.

1, 5, 7

II

4. State desired endpoints of therapy and identifies appropriate monitoring parameters.

5

I, II

5. Identify potential drug induced problems and adverse effects and their incidence, significance, and management.

5, 7

II

6. Retrieve, integrate and apply information acquired across the pharmacy curriculum into patient care and management.

5, 7

V

7. Develop critical thinking skills in patient and problem assessment.

2

V

8. Develop an appreciation for the interrelationship of multiple medical problems in the pharmaceutical care of the patient.

4, 5

V

9. Anticipate possible outcomes and identify alternate plans in response to a recommended pharmaceutical care plan.

5

II, VI

 

ACTIVE LEARNING

METHODS:

Students are asked to prepare selected case studies in class and then discuss them with instructors and fellow students.

 

 

INSTRUCTIONAL
METHODS:

 

Pharmacotherapeutics is a “turn” taught course.  Instructors with expertise in each of the subject areas will provide six (6) hours of didactic instruction per week in both the fall and spring semesters.

 

The recitation/case study portion of the class will be divided into two groups with one group meeting Mondays and the other Wednesdays.  Instructor(s) will provide cases for each group two Fridays preceding that week of cases. Each class member will be expected to research the case(s) and rewrite into a case presentation format.  IORs of the case study sessions will call upon students randomly and expect them to discuss the etiology, pathophysiology, diagnosis, and pharmacotherapy issues relative to the case.

Distance students will be assigned to a group of 6-7 students and will receive the same cases as the campus students.  At their assigned time, each group will log in to a CULive session with their assigned mentor.  The mentor will call upon students randomly and expect them to discuss the etiology, pathophysiology, diagnosis, and pharmacotherapy issues relative to the case.

 

 

EXAMINATIONS/

QUIZZES:

Six section examinations will be scheduled to total 400 points.  The final will consist of 100 points from previously covered material. A two hour block will be provided for examinations.  The instructor responsible for the section(s) being tested will provide questions to the instructor of record (IOR).  New material questions may consist of short answer, essay, multiple-choice, or true-false any of which can be based on a patient case. Comprehensive questions may be in the form of multiple choice or true/false. A five-point quiz will be given during each of the scheduled case study sessions. Students with unexcused absences from case study will NOT be offered a make-up quiz.

 

The student is responsible for contacting the IOR prior to any absence on the date of a scheduled examination.  The IOR will determine whether an excused absence will be granted.  If an excused absence is granted, the student must complete a makeup examination within 1 week of the scheduled exam.  Any unexcused absence from an examination will result in the student obtaining a score of zero for that examination. Challenges to the grading of any exam must be made with either the instructor providing the material or the IOR within 10 school days of receiving back the exam.

 

 

CASE STUDY

ATTIRE:

It will be expected of the student to follow the rotation dress code during case study with the exception that neckties are optional.

 

 

GRADING:

Students are graded based on examination performance, case study quiz scores, and case study presentations. Five hundred (500) points will be available from examinations, 60 points available from case study quizzes, and 50 points from case study presentations.

                                                       

Attendance will be required for campus students for the lecture portion of this course.  Students will be allowed 3 absences without penalty.  A reduction of 3 points from the total examination score will be imposed for each absence beyond 3, and these point deductions will be enforced prior to the final calculation of the exam score and final grade.

 

In addition to achieving a passing score for the overall course, the student MUST HAVE achieved 350/500 exam points, 77/110 case study points, AND 70/100 comprehensive exam points at the end of the semester in order to successfully pass the course. There is no opportunity for extra credit.

 

 

GRADING SCALE:

A   

B+

B   

C+

C   

F   

³ 549 points

>518 to <549 points

>488 to <518 points

>457 to <488 points

>427 to <457 points

< 427 points

 

 

SCHEDULE OF:

 

LECTURES:

The most up to date information should be retrieved from the course website.

 

 

 

REQUIRED TEXT:

 

Pharmacotherapy.jpg (37191 bytes)
Pharmacotherapy - A Pathophysiologic Approach, 7th Ed.  Edited by Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells, BG, and Posey LM.

 

 

INSTRUCTOR   

OF RECORD:

Keith Christensen, Pharm.D., BCPS

kchristensen@creighton.edu

 

 

DISTANCE

COORDINATOR:

Eric Hoie, Pharm D

 

 

CASE STUDY

COORDINATOR:

Amy Pick, Pharm D

CUMC Residents

 

This technology readiness assessment is my attempt to ascertain your current technology resources in order to determine your ability to complete this course work with the technology that is going to be used.

Click HERE to access this required survey

(back to top)

 

Copyright 2009   Keith Christensen, Pharm D, BCPS